SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
WARSAW, Ind., April 09, 2018 -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it will continue its Diamond sponsorship for the 37th Annual European Paediatric Orthopaedic Society (EPOS) meeting, which will take place April 11 – 14 in Oslo, Norway. OrthoPediatrics has been a leading sponsor of the Society since the Company’s inception.
At the meeting, OrthoPediatrics will also sponsor a lunch symposium titled “Management of Open Fractures in Children”, featuring a panel of key opinion leaders from around the world. The panelists will discuss the most frequent types of fractures, guidelines for antibiotic use, evidence-based surgical treatment and the management of soft tissue injuries in open fractures in children. The panel will be moderated by Dr. Pierre Journeau, with additional discussion and case presentations by Drs. Annelie Weinberg, Manoj Ramachandran, and Manon Bachy.
OrthoPediatrics’ President & CEO Mark Throdahl, commented, “We are pleased to continue our leading support of EPOS, one of the world’s largest pediatric orthopedic scientific organizations. This society has remained steadfastly dedicated to elevating the quality of care for children with orthopedic conditions. OrthoPediatrics has shared this mission since our inception, and so we are proud to continue supporting the clinical education of pediatric surgeons as we work together to improve the lives of children with orthopedic conditions around the world.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 24 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 37 countries outside the United States.
Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
[email protected] / [email protected]
